Follow-up of patients Using Artificial Intelligence During The Pandemic and Its Application In The Diagnosis of Leukemia
Abstract
The prestige of the recent technologies such as “deep learning”, “internet of things (IoT)”, “cloud technology”, “big data”, “machine learning” are increasing day by day, and “artificial intelligence (AI)” is one of the most important components that pave the way for the development and transformation of those technologies. Recently, the use of artificial intelligence in medicine has become gradually widespread, and “artificial intelligence technologies” can be used in various fields of medicine today. Similarly, computer aided diagnosis (CAD) methods have been employed more and more extensively in medicine. A variety of “machine learning algorithms” have also been generated to diagnose several diseases such as “leukaemia”. As it is well-known, a fast, safe and accurate early-stage diagnosis of leukaemia is a crucial factor in healing patients and saving their lives. The current study, which is based on a method of artificial intelligence, aimed to investigate the use of internet of medical things (IoMT) to enable and improve a rapid and safe diagnosis of leukaemia. In the proposed IoMT system, medical devices and tools are connected to network with the help of cloud computing. In this system, the techniques used to identify the subtypes of leukaemia were “residual convolutional neural network” (ResNet-34) and “dense convolutional neural network” (DenseNet-121). By means of data magnification techniques, ResNet-34 and DenseNet-121 were both put into service to process multiple image patterns. For all healthy cases, the estimation accuracy of ResNet-34 and DenseNet-121 was measured as 100% and the precision rate was found to be 100%.
Keywords
References
- 1. McCarthy J. What is artificial intelligence? Computer Science Department, Stanford University. Available from: http://www-formal.stanford.edu/jmc/whatisai.pdf
- 2. Bibi N, Sikandar M, Ikram Ud Din, Almogren A, “IoMT-Based Automated Detection and Classification of Leukemia Using Deep Learning”, Journal of Healthcare Engineering, 2020, Article ID 6648574, 12 pages.
- 3. Awan K A, Din IU, Almogren A, Almajed H, Mohiuddin I, Guizani M. Neurotrust-artificial neural network-based intelligent trust management mechanism for large-scale internet of medical things. IEEE Internet of Things Journal. 2020;8.
- 4. Almogren A, Mohiuddin I, Din IU. Al Majed H. Ftm-iomt: Fuzzy-based trust management for preventing sybil attacks in internet of medical things. IEEE Internet of Things Journal. 2020;8
- 5. Demirhan A, Kılıç YA, Güler İ, “Tıpta Yapay Zeka Uygulamaları”, Yoğun Bakım Dergisi 2010, 9(1), 31-41.
- 6. Wujcik D. Molecular Biology of Leukemia. Semin Oncol Nurs, 2003; 19(2): 83-89.
- 7. Devine H, DeMeyer E. Hematopoietic cell transplantation in the treatment of leukemia. Semin Oncol Nurs, 2003; 19(2):118-132.
- 8. Ruddon R. W. Cancer Biology, Third Edition. New York, Oxford University pres,1995; 78-79, 28-29.
Details
Primary Language
English
Subjects
Clinical Sciences, Engineering
Journal Section
Research Article
Publication Date
September 30, 2021
Submission Date
July 8, 2021
Acceptance Date
September 30, 2021
Published in Issue
Year 2021 Volume: 1 Number: 2
APA
Güler Kazancı, E., & Büyükkaya, E. (2021). Follow-up of patients Using Artificial Intelligence During The Pandemic and Its Application In The Diagnosis of Leukemia. Artificial Intelligence Theory and Applications, 1(2), 54-63. https://izlik.org/JA54FP48MP
AMA
1.Güler Kazancı E, Büyükkaya E. Follow-up of patients Using Artificial Intelligence During The Pandemic and Its Application In The Diagnosis of Leukemia. AITA. 2021;1(2):54-63. https://izlik.org/JA54FP48MP
Chicago
Güler Kazancı, Elif, and Emine Büyükkaya. 2021. “Follow-up of Patients Using Artificial Intelligence During The Pandemic and Its Application In The Diagnosis of Leukemia”. Artificial Intelligence Theory and Applications 1 (2): 54-63. https://izlik.org/JA54FP48MP.
EndNote
Güler Kazancı E, Büyükkaya E (September 1, 2021) Follow-up of patients Using Artificial Intelligence During The Pandemic and Its Application In The Diagnosis of Leukemia. Artificial Intelligence Theory and Applications 1 2 54–63.
IEEE
[1]E. Güler Kazancı and E. Büyükkaya, “Follow-up of patients Using Artificial Intelligence During The Pandemic and Its Application In The Diagnosis of Leukemia”, AITA, vol. 1, no. 2, pp. 54–63, Sept. 2021, [Online]. Available: https://izlik.org/JA54FP48MP
ISNAD
Güler Kazancı, Elif - Büyükkaya, Emine. “Follow-up of Patients Using Artificial Intelligence During The Pandemic and Its Application In The Diagnosis of Leukemia”. Artificial Intelligence Theory and Applications 1/2 (September 1, 2021): 54-63. https://izlik.org/JA54FP48MP.
JAMA
1.Güler Kazancı E, Büyükkaya E. Follow-up of patients Using Artificial Intelligence During The Pandemic and Its Application In The Diagnosis of Leukemia. AITA. 2021;1:54–63.
MLA
Güler Kazancı, Elif, and Emine Büyükkaya. “Follow-up of Patients Using Artificial Intelligence During The Pandemic and Its Application In The Diagnosis of Leukemia”. Artificial Intelligence Theory and Applications, vol. 1, no. 2, Sept. 2021, pp. 54-63, https://izlik.org/JA54FP48MP.
Vancouver
1.Elif Güler Kazancı, Emine Büyükkaya. Follow-up of patients Using Artificial Intelligence During The Pandemic and Its Application In The Diagnosis of Leukemia. AITA [Internet]. 2021 Sep. 1;1(2):54-63. Available from: https://izlik.org/JA54FP48MP